- Home
- DARE vs MGRX Comparison
DARE vs MGRX Comparison
Compare DARE & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- MGRX
- Stock Information
- Founded
- DARE 2015
- MGRX 2021
- Country
- DARE United States
- MGRX United States
- Employees
- DARE N/A
- MGRX N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- MGRX Computer Software: Prepackaged Software
- Sector
- DARE Health Care
- MGRX Technology
- Exchange
- DARE Nasdaq
- MGRX Nasdaq
- Market Cap
- DARE 28.0M
- MGRX 23.3M
- IPO Year
- DARE N/A
- MGRX 2023
- Fundamental
- Price
- DARE $2.25
- MGRX $2.45
- Analyst Decision
- DARE Strong Buy
- MGRX
- Analyst Count
- DARE 2
- MGRX 0
- Target Price
- DARE $10.00
- MGRX N/A
- AVG Volume (30 Days)
- DARE 123.3K
- MGRX 177.2K
- Earning Date
- DARE 11-13-2025
- MGRX 11-13-2025
- Dividend Yield
- DARE N/A
- MGRX N/A
- EPS Growth
- DARE N/A
- MGRX N/A
- EPS
- DARE N/A
- MGRX N/A
- Revenue
- DARE N/A
- MGRX $516,030.00
- Revenue This Year
- DARE $6,864.02
- MGRX N/A
- Revenue Next Year
- DARE $4,922.46
- MGRX N/A
- P/E Ratio
- DARE N/A
- MGRX N/A
- Revenue Growth
- DARE N/A
- MGRX N/A
- 52 Week Low
- DARE $1.83
- MGRX $1.32
- 52 Week High
- DARE $9.19
- MGRX $6.15
- Technical
- Relative Strength Index (RSI)
- DARE 61.86
- MGRX 58.43
- Support Level
- DARE $2.11
- MGRX $2.04
- Resistance Level
- DARE $2.28
- MGRX $2.66
- Average True Range (ATR)
- DARE 0.07
- MGRX 0.26
- MACD
- DARE 0.02
- MGRX 0.01
- Stochastic Oscillator
- DARE 91.96
- MGRX 71.19
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.